2037 W CARROLL AVE CHICAGO, IL 60612 Get Directions
2037 W CARROLL AVE CHICAGO, IL 60612 Get Directions
Aquarius Biotechnologies, LLC ("Aquarius") uses a proprietary drug delivery technology to improve existing drugs. Specifically, Aquarius reformulates drugs that are only available intravenously to make them available orally. Thus, instead of a patient needing to get an injection, they can swallow a pill. In addition, Aquarius' technology has been shown to reduce the toxicity of drugs and increase the shelf life of drugs.
The lead products using Aquarius' technology are both in the anti-infective space. Aquarius develops these products through a certain point in the FDA regulatory approval process, then forms partnerships with pharmaceutical companies that complete the drug development process.
© Dun & Bradstreet, Inc. 2024. All rights reserved.
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.